Rhinosinusitis: Establishing definitions for clinical research and patient care

Eli O. Meltzer; Daniel L. Hamilos; James A. Hadley; Donald C. Lanza; Bradley F. Marple; Richard A. Nicklas; Claus Bachert; James Baraniuk; Fuad M. Baroody; Michael S. Benninger; Itzhak Brook; Badrul A. Chowdhury; Howard M. Druce; Stephen Durham; Berrylin Ferguson; Jack M. Gwaltney; Michael Kaliner; David W. Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F. Piccirillo; Patricia Rohane; Ronald Simon; Raymond G. Slavin; Alkis Togias; Ellen R. Wald; S. James Zinreich

Rhinosinusitis: Establishing definitions for clinical research and patient care

Eli O. Meltzer, Daniel L. Hamilos, James A. Hadley, Donald C. Lanza, Bradley F. Marple, Richard A. Nicklas, Claus Bachert, James Baraniuk, Fuad M. Baroody, Michael S. Benninger, Itzhak Brook, Badrul A. Chowdhury, Howard M. Druce, Stephen Durham, Berrylin Ferguson, Jack M. Gwaltney, Michael Kaliner, David W. Kennedy, Valerie Lund, Robert NaclerioRuby Pawankar, Jay F. Piccirillo, Patricia Rohane, Ronald Simon, Raymond G. Slavin, Alkis Togias, Ellen R. Wald, S. James Zinreich

Research output: Contribution to journal › Article › peer-review

352 Scopus citations

Original language	English
Pages (from-to)	S1-S62
Journal	Otolaryngology - Head and Neck Surgery
Volume	131
Issue number	6 SUPPL.
State	Published - Dec 2004

Cite this

Meltzer, E. O., Hamilos, D. L., Hadley, J. A., Lanza, D. C., Marple, B. F., Nicklas, R. A., Bachert, C., Baraniuk, J., Baroody, F. M., Benninger, M. S., Brook, I., Chowdhury, B. A., Druce, H. M., Durham, S., Ferguson, B., Gwaltney, J. M., Kaliner, M., Kennedy, D. W., Lund, V., ... Zinreich, S. J. (2004). Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngology - Head and Neck Surgery, 131(6 SUPPL.), S1-S62.

@article{11238fdb1197462cb085888d4700b0f1,

title = "Rhinosinusitis: Establishing definitions for clinical research and patient care",

author = "Meltzer, {Eli O.} and Hamilos, {Daniel L.} and Hadley, {James A.} and Lanza, {Donald C.} and Marple, {Bradley F.} and Nicklas, {Richard A.} and Claus Bachert and James Baraniuk and Baroody, {Fuad M.} and Benninger, {Michael S.} and Itzhak Brook and Chowdhury, {Badrul A.} and Druce, {Howard M.} and Stephen Durham and Berrylin Ferguson and Gwaltney, {Jack M.} and Michael Kaliner and Kennedy, {David W.} and Valerie Lund and Robert Naclerio and Ruby Pawankar and Piccirillo, {Jay F.} and Patricia Rohane and Ronald Simon and Slavin, {Raymond G.} and Alkis Togias and Wald, {Ellen R.} and Zinreich, {S. James}",

note = "Funding Information: Disclosure of potential conflict of interest: E. O. Meltzer has consulting arrangements with Alcon, Altana, AstraZeneca, Aventis, Dey, Genentech, GlaxoSmithKline, Merck, Medpointe, Novartis, Pfizer, Schering-Plough, and Wyeth; receives grants-research support from Alcon, Altana, AstraZeneca, Aventis, Dey, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, and Schering-Plough; and is on the Speaker{\textquoteright}s Bureau for Aventis, AstraZeneca, Genentech, GlaxoSmithKline, Merck, Pfizer, and Schering-Plough, D. L. Hamilos—none disclosed. J. Hadley has consultant arrangements with Abbott, Aventis, Bayer, GlaxoSmithKline, Merck, GE Medical Systems, Pfizer, and Schering-Plough and is on the Speaker{\textquoteright}s Bureau for Abbott, Aventis, Bayer, GlaxoSmithKline, Merck, Pfizer, and Schering-Plough. D. Lanza is on the Speaker{\textquoteright}s Bureau for AstraZeneca. B. F. Marple has consulting arrangements with Alcon, Aventis, and Bayer and receives grants-research support from Aventis, GlaxoSmithKline, Abbott, Merck, and Bayer. R. Nicklas—none disclosed. C. Bachert—none disclosed. J. Baraniuk has consultant arrangements with Roche, Centecor, GlaxoSmithKline, Astra-Zeneca, and Aventis; has patent-licensing arrangements with Georgetown University; receives grants-research support from the National Institutes of Health; and is employed by Georgetown University. F. M. Baroody is on the Speaker{\textquoteright}s Bureau for Merck & Co, Inc, and GlaxoSmithKline. M. S. Benninger has consultant arrangements with Aventis, GlaxoSmithKline, Ortho-McNeil, Abbott, and Bayer; receives grants-research support from Novartis and Bayer; is on the Speaker{\textquoteright}s Bureau for Aventis and GlaxoSmithKline. I. Brook is on the Speaker{\textquoteright}s Bureau for Abbott. B. A. Chowdhury—none disclosed. H. M. Druce is employed by Phys Inc. S. Durham has consultant arrangements with ALK Abello, UCB, and GlaxoSmithKline; receives grants-research support from ALK Abello and GlaxoSmithKline; and is on the Speaker{\textquoteright}s Bureau for ALK Abello, UCB, Aventis, and WAO. B. Ferguson has consulting arrangements with Aventis, Abbott, and GlaxoSmithKline; is on the Speaker{\textquoteright}s Bureau for Aventis, Astra Zeneca, Abbott, Merck, GlaxoSmithKline, and Pfizer; and is an advisor for Pfizer. J. M. Gwaltney, Jr—none disclosed. M. Kaliner has consultant arrangements with Aventis, Novartis, GlaxoSmithKline, Genentech, and Abbott; receives grants-research support from Astra Zeneca, Aventis, Boehringer-Ingelheim, GlaxoSmithKline, and Schering-Plough; is on the Speaker{\textquoteright}s Bureau for Aventis, Abbott, GlaxoSmithKline, Medpointe, Novartis, and Genentech. D. Kennedy has consulting arrangements with Aventis, Novartis, Medtronic-Xomed, and Schering-Plough; received grants-research support from Novartis; and has patent-licensing arrangements with Medtronic-Xomed. V. Lund has consulting arrangements with Schering-Plough and Bayer. R. Naclerio has consulting arrangements with Merck and Schering-Plough; receives grants-research support from Corixa and Merck; and is on the Speaker{\textquoteright}s Bureau for Merck and GlaxoSmithKline. R. Pawankar—none disclosed. J. F. Piccirillo—none disclosed. P. Rohane is employed by Celgene Corp. R. Simon—none disclosed. R. Slavin has consultant arrangements with Aventis; receives grants-research support from GlaxoSmithKline, Genentech, and AstraZeneca; and is on the Speaker{\textquoteright}s Bureau of Aventis, Schering-Plough, Genentech, and AstraZeneca. A. Togias has consultant arrangement with AstraZeneca, Genentech, GlaxoSmithKline, Novartis, and Merck; receives grants-research support from Merck and Genentech; and is on the Speaker{\textquoteright}s Bureau for Genentech, Merck, Novartis, Pfizer, and UCB. E. R. Wald receives grants-research support from Aventis, GlaxoSmithKline, Wyeth, Abbott, and Medimmune. J. Zinreich—none disclosed. ",

year = "2004",

month = dec,

language = "English",

volume = "131",

pages = "S1--S62",

journal = "Otolaryngology - Head and Neck Surgery",

issn = "0194-5998",

number = "6 SUPPL.",

}

Meltzer, EO, Hamilos, DL, Hadley, JA, Lanza, DC, Marple, BF, Nicklas, RA, Bachert, C, Baraniuk, J, Baroody, FM, Benninger, MS, Brook, I, Chowdhury, BA, Druce, HM, Durham, S, Ferguson, B, Gwaltney, JM, Kaliner, M, Kennedy, DW, Lund, V, Naclerio, R, Pawankar, R, Piccirillo, JF, Rohane, P, Simon, R, Slavin, RG, Togias, A, Wald, ER & Zinreich, SJ 2004, 'Rhinosinusitis: Establishing definitions for clinical research and patient care', Otolaryngology - Head and Neck Surgery, vol. 131, no. 6 SUPPL., pp. S1-S62.

TY - JOUR

T1 - Rhinosinusitis

T2 - Establishing definitions for clinical research and patient care

AU - Meltzer, Eli O.

AU - Hamilos, Daniel L.

AU - Hadley, James A.

AU - Lanza, Donald C.

AU - Marple, Bradley F.

AU - Nicklas, Richard A.

AU - Bachert, Claus

AU - Baraniuk, James

AU - Baroody, Fuad M.

AU - Benninger, Michael S.

AU - Brook, Itzhak

AU - Chowdhury, Badrul A.

AU - Druce, Howard M.

AU - Durham, Stephen

AU - Ferguson, Berrylin

AU - Gwaltney, Jack M.

AU - Kaliner, Michael

AU - Kennedy, David W.

AU - Lund, Valerie

AU - Naclerio, Robert

AU - Pawankar, Ruby

AU - Piccirillo, Jay F.

AU - Rohane, Patricia

AU - Simon, Ronald

AU - Slavin, Raymond G.

AU - Togias, Alkis

AU - Wald, Ellen R.

AU - Zinreich, S. James

N1 - Funding Information: Disclosure of potential conflict of interest: E. O. Meltzer has consulting arrangements with Alcon, Altana, AstraZeneca, Aventis, Dey, Genentech, GlaxoSmithKline, Merck, Medpointe, Novartis, Pfizer, Schering-Plough, and Wyeth; receives grants-research support from Alcon, Altana, AstraZeneca, Aventis, Dey, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, and Schering-Plough; and is on the Speaker’s Bureau for Aventis, AstraZeneca, Genentech, GlaxoSmithKline, Merck, Pfizer, and Schering-Plough, D. L. Hamilos—none disclosed. J. Hadley has consultant arrangements with Abbott, Aventis, Bayer, GlaxoSmithKline, Merck, GE Medical Systems, Pfizer, and Schering-Plough and is on the Speaker’s Bureau for Abbott, Aventis, Bayer, GlaxoSmithKline, Merck, Pfizer, and Schering-Plough. D. Lanza is on the Speaker’s Bureau for AstraZeneca. B. F. Marple has consulting arrangements with Alcon, Aventis, and Bayer and receives grants-research support from Aventis, GlaxoSmithKline, Abbott, Merck, and Bayer. R. Nicklas—none disclosed. C. Bachert—none disclosed. J. Baraniuk has consultant arrangements with Roche, Centecor, GlaxoSmithKline, Astra-Zeneca, and Aventis; has patent-licensing arrangements with Georgetown University; receives grants-research support from the National Institutes of Health; and is employed by Georgetown University. F. M. Baroody is on the Speaker’s Bureau for Merck & Co, Inc, and GlaxoSmithKline. M. S. Benninger has consultant arrangements with Aventis, GlaxoSmithKline, Ortho-McNeil, Abbott, and Bayer; receives grants-research support from Novartis and Bayer; is on the Speaker’s Bureau for Aventis and GlaxoSmithKline. I. Brook is on the Speaker’s Bureau for Abbott. B. A. Chowdhury—none disclosed. H. M. Druce is employed by Phys Inc. S. Durham has consultant arrangements with ALK Abello, UCB, and GlaxoSmithKline; receives grants-research support from ALK Abello and GlaxoSmithKline; and is on the Speaker’s Bureau for ALK Abello, UCB, Aventis, and WAO. B. Ferguson has consulting arrangements with Aventis, Abbott, and GlaxoSmithKline; is on the Speaker’s Bureau for Aventis, Astra Zeneca, Abbott, Merck, GlaxoSmithKline, and Pfizer; and is an advisor for Pfizer. J. M. Gwaltney, Jr—none disclosed. M. Kaliner has consultant arrangements with Aventis, Novartis, GlaxoSmithKline, Genentech, and Abbott; receives grants-research support from Astra Zeneca, Aventis, Boehringer-Ingelheim, GlaxoSmithKline, and Schering-Plough; is on the Speaker’s Bureau for Aventis, Abbott, GlaxoSmithKline, Medpointe, Novartis, and Genentech. D. Kennedy has consulting arrangements with Aventis, Novartis, Medtronic-Xomed, and Schering-Plough; received grants-research support from Novartis; and has patent-licensing arrangements with Medtronic-Xomed. V. Lund has consulting arrangements with Schering-Plough and Bayer. R. Naclerio has consulting arrangements with Merck and Schering-Plough; receives grants-research support from Corixa and Merck; and is on the Speaker’s Bureau for Merck and GlaxoSmithKline. R. Pawankar—none disclosed. J. F. Piccirillo—none disclosed. P. Rohane is employed by Celgene Corp. R. Simon—none disclosed. R. Slavin has consultant arrangements with Aventis; receives grants-research support from GlaxoSmithKline, Genentech, and AstraZeneca; and is on the Speaker’s Bureau of Aventis, Schering-Plough, Genentech, and AstraZeneca. A. Togias has consultant arrangement with AstraZeneca, Genentech, GlaxoSmithKline, Novartis, and Merck; receives grants-research support from Merck and Genentech; and is on the Speaker’s Bureau for Genentech, Merck, Novartis, Pfizer, and UCB. E. R. Wald receives grants-research support from Aventis, GlaxoSmithKline, Wyeth, Abbott, and Medimmune. J. Zinreich—none disclosed.

PY - 2004/12

Y1 - 2004/12

UR - http://www.scopus.com/inward/record.url?scp=9644268271&partnerID=8YFLogxK

M3 - Article

C2 - 15577816

AN - SCOPUS:9644268271

SN - 0194-5998

VL - 131

SP - S1-S62

JO - Otolaryngology - Head and Neck Surgery

JF - Otolaryngology - Head and Neck Surgery

IS - 6 SUPPL.

ER -

Rhinosinusitis: Establishing definitions for clinical research and patient care

Other files and links

Cite this